차백신연구소
CHA Vaccine Institute’s
Proprietary Adjuvant
Joins CEPI’s Vaccine Adjuvant Library
CHA Vaccine Institute (KOSDAQ: 261780) announced that its proprietary adjuvant, Lipo-pam™, has been officially included in the “Vaccine Adjuvant Library” established by the Coalition for Epidemic Preparedness Innovations (CEPI). CEPI…
